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1CHAPTER I
INTRODUCTION
Conjugated linoleic acid (CLA) refers to a group of positional and geometric 
isomers of linoleic acid (LA; c9c12-C18:2) (MacDonald 2000).  The major isomer is the 
c9t11 octadecadienoic acid (Kepler and Tove 1967), which has been suggested to be the 
most biologically active (Ha and others 1990).  It has shown to be antioxidative (Ip and 
others 1991), anticarcinogenic (Pariza and Hargraves 1985; Pariza 1997), and 
antiatherosclerotic (Lee and others 1994; Wilson and others 2000) 
Formation of CLA can be achieved by chemical synthesis (Christie and others 
1997), by rumen bacteria (Bauman and others 1999) or by lactic acid bacteria (LAB) 
(Ogawa and others 2001).  Among LAB the genus Lactobacillus has gained recent 
attention because of their other potentially beneficial properties.  For instance, they can 
control cancer (Kasper 1998) and lower serum cholesterol (Gilliland 1990).
Lactobacillus reuteri, a probiotic that highly effectively enzymatically transforms 
LA into CLA (Pariza and Yang 1998), is also bile resistant (De Boever and others 2000).  
This is an important property for its survival and establishment in the intestinal tract 
(Gilliland 1990).
Studies on L. reuteri showed that exposure to bile acids produced modifications in 
cell permeability (Taranto and others 2003).  Thus since linoleate isomerase, the enzyme
2responsible for CLA production is intracellular (Pariza and Yang 1998), it may be that 
the presence of glycocholic acid, a major bile acid (Brashears and others 1998) could 
improve its performance.  The purpose of this study was to investigate the influence of 
glycocholic acid on CLA production by L. reuteri 55739.
3CHAPTER II
REVIEW OF LITERATURE
Conjugated Linoleic Acid and its Benefits
Chemistry of Conjugated Linoleic Acid
Conjugated Linoleic Acid (CLA) is a group of positional and geometric isomers 
of linoleic acid, c9c12-C18:2 (MacDonald 2000).  The major isomers found in CLA are 
c9t11-, t9c11-, t9t11-, t10t12-, and t10c12-octadecadienoic acids, however CLA also 
includes, in less amount, c9c11-, t9c11-, c10c12-, c10t12-, and c11c13- octadecadienoic 
acids (Ha and others 1989).
Formation of Conjugated Linoleic Acid by Chemical Synthesis
The synthesis of CLA can be done commercially by alkaline isomerization of 
linoleic acid resulting in a mixture of four (8,10-, 9,11-, 10,12-, and 11,13 – C18:2) 
cis/trans positional isomers (Christie and others 1997).  It also can be synthesized 
chemically via dehydration of castor oil (Padley and others 1994) or by using methyl 
ricinoleate purified from castor oil to produce methyl c9t11-C18:2 instead of just c9t11-
C18:2 (Berdeaux and others 1997).  Production is also possible through oxidation of 
linoleic acid free radicals in the presence of sulfur-rich proteins (Dormandy and Wickens 
1987).  Jung and others (2001) demonstrated that it is possible to produce soybean oil 
with a high CLA content by hydrogenation.  This procedure involves the use of a 
4selective Ni catalyst under high temperatures (210 ºC), with agitation (300 rpm) for a 
short period of time (10 min). 
Formation of Conjugated Linoleic Acid in the Rumen
The unsaturated fatty acids linolenic (C18:3) and linoleic (c9c12-C18:2) acid 
found in forages as well as triglycerides containing linoleic and oleic acid (c9-C18:1) 
found in seed oils undergo an initial hydrolysis of the ester linkages by microbial lipases 
prior to the biohydrogenation process in the rumen (Dawson and Kemp 1970).  
Butyrivibrio fibrisolvens as well as a diverse range of other rumen bacteria have the 
capacity to biohydrogenate unsaturated fatty acids (Bauman and others 1999).  Several 
biochemical steps and different species of rumen bacteria are involved in the complete 
biohydrogenation of unsaturated lipids (Kemp and Lander 1984).  Biohydrogenation of 
linoleic acid starts with the isomerization of the cis-12 double bond by the linoleate 
isomerase to yield the major isomer of CLA, c9t11 (Kepler and Tove 1967).  A second 
reaction takes place in which c9t11-C18:2 is rapidly transformed to vaccenic acid (t11-
C18:1).  Finally, t11-C18:1 is slowly hydrogenated into stearic acid (C18:0) (Tanaka and 
Shigeno 1976).  Because of the slow reduction, t11-C18:1 accumulates in the rumen 
making it more available for absorption (Bauman and others 1999).  Modifications in the 
biohydrogenation pathways and end products formed can occur as result of changes in 
populations of rumen bacteria (Leat and others 1977) due to decreased pH (Bauman and 
others 1999).
5Formation of Conjugated Linoleic Acid in Animal Tissue and Milk
There are two sources for the CLA found in meat and milk products of ruminants.  
The CLA is formed during ruminal biohydrogenation of linoleic acid as well as being 
synthesized in the animal’s tissues from t11-C18:1, an intermediate in the 
biohydrogenation of unsaturated fatty acids (Bauman and others 1999).  Several studies 
have shown that the concentration of t11-C18:1 isomer is positively correlated to c9t11-
C18:2 concentrations in milk fat (Jiang and others 1996; Bauman and others 1999).  This 
close relationship has been explained by the presence of high concentrations of 
9desaturase in adipose tissue of growing ruminants (Corl and others 1998, 1999), which 
seems to be the major site of endogenous synthesis of c9t11-C18:2 from t11-C18:1.  The 
mammary gland contains adipose tissue, which displaces the apparent site of endogenous 
synthesis of c9t11-C18:2 for lactating ruminants (Bickerstaffe and Annison 1970).  The 
content of CLA in fat from ruminant-derived food products depends on the dietary intake 
by the ruminant of linoleic acid (Bartlet and Chapman 1961; Parodi 1977), the ruminal 
production of both CLA and t11-C18:1 by microbial metabolism and the tissue activity of 
9desaturase (Bauman and others 1999).  Similarly, the content of CLA found in the 
tissue of nonruminants is synthesized by microorganisms in the gastrointestinal tract that 
use linoleic acid as a substrate (Chin and others 1992).
Formation of Conjugated Linoleic Acid by Lactic Acid Bacteria
The c9t11-C18:2 isomer has been shown to be the most important isomer in terms 
of biological activity.  Apparently, it is the only isomer incorporated into the 
phospholipid fraction of tissue of animals fed a mixture of CLA isomers (Ha and others 
61990).  This has triggered an interest in the development of methods, including the use of 
bacteria for the selective production of CLA isomers (Ogawa and others 2001).  Jiang 
and others (1998) reported that a dairy starter culture, Propinibacterium freudenreichii, 
had the ability to produce CLA using free linoleic acid as a substrate.  This study 
suggested that, CLA is derived from linoleic acid.  Furthermore, they suggested that 
among CLA producing strains, there is positive correlation between CLA production and 
tolerance to free linoleic acid.  However, Jenkins and Courtney (2003) found that, in 
MRS broth, the strains capable of producing CLA are the most inhibited by linoleic acid
while those that cannot produce CLA are the least affected.  Interestingly, in both 
previous studies, the authors had almost the same conclusion that linoleic acid 
isomerization to CLA is a detoxification mechanism for survival purposes, respectively 
for Jiang and others (1998), and Jenkins and Courtney (2003). 
The CLA produced by cultures of lactobacilli is mainly present in the 
extracellular phase (Jiang and others 1998), but is also incorporated into the cellular 
membrane when grown in the presence of exogenous linoleic acid.  It is important to 
mention that there is no association between the amount of fatty acid incorporated into 
the membrane and the inhibition of growth by that fatty acid (Jenkins and Courtney 
2003).  The metabolic pathway by which lactic acid bacteria generally transform free 
linoleic acid into CLA may be explained as follows: lactic acid bacteria under 
microaerobic conditions produce hydroxy fatty acids, 10-hydroxy-cis-12-octadecaenoic 
acid and 10-hydroxy-trans-12-octadecaenoic acid, which were found as possible 
precursors of the CLA isomers c9t11- or t9c11- C18:2 (Ogawa and others 2001).  The 
accumulation of c9-C18:1, in the extracellular phase, during production of c9t11- or 
7t9c11 –C18:2 by lactic acid bacteria from medium containing free linoleic acid indicates 
that some c9t11- or t9c11 –C18:2 are further hydrogenated to c9-C18:1 instead of t11-
C18:1, which is similar to what takes place in the bovine rumen (Jiang and others 1998).  
The conversion of free linoleic acid into CLA by lactobacilli is catalyzed by linoleate 
isomerase, a membrane bound enzyme (Pariza and Yang 1998).  Studies by Pariza and 
Yang (1998), show detailed biochemical characteristics of Lactobacillus reuteri.  First, 
the production of CLA is directly proportional to the cell biomass.  Second, there is an 
enzyme conversion of linoleic acid mainly to the c9t11-C18:2 isomer without producing 
the t10c12 or the c10c12 isomers.  These findings suggest that linoleate isomerase is an 
enzyme that accumulates, is not required for cell growth, and has a degree of specificity 
on cis-12, instead of cis-9 double bond of the fatty acid.  The reaction between the 
linoleate isomerase of L. reuteri and the free fatty acids can be accomplished in the early 
stationary phase (Pariza and Yang 1998).  Studies on Lactobacillus acidophilus found 
that cells previously subcultured in medium containing linoleic acid had a higher CLA 
productivity than cells grown in medium without linoleic acid.  This suggests that the 
enzyme system for CLA production is induced by linoleic acid (Ogawa and others 2001).  
The presence of various medium components such as albumin, starch, cholesterol and 
lecithin help protect bacteria from free fatty acids during their growth (Nieman 1954).  
Tween-80 or proteins have an important function in the recovery of the inhibitory effects 
of free linoleic acid aiding in the production of CLA in MRS broth (Jiang and others 
1998).  However, inhibition of Lactobacillus is less in skim milk than in MRS broth with 
equal concentration of linoleic acid (Jenkins and Courtney 2003).  Furthermore, milk 
proteins or other components may provide a higher protective effect against fatty acids 
8than MRS broth (Lin and others 1999).  However, the complete mechanisms of CLA 
production by lactic acid bacteria remain unclear.
Occurrence of Conjugated Linoleic Acid in Foods 
Conjugated linoleic acid is found in a wide array of biological materials, 
including plants and animal tissues, normally consumed by humans.  The main dietary 
source of CLA are animal products, of which ruminants are the greatest contributors.  
Seventy-six percent of the CLA in meat products from ruminants is the c9t11-C18:2 
isomer (Chin and others 1992).  This is due to the incomplete biohydrogenation of dietary 
unsaturated fatty acids in the rumen (Bauman and others 1999).  Of meat from ruminant 
animals, lamb has the highest concentration of CLA with 5.6 mg CLA/g fat, followed by 
beef which ranges from 2.9 to 4.3 mg CLA/g fat, while veal has the lowest with 2.7 mg 
CLA/g fat.  Foods derived from non-ruminants are far lower in CLA content except for 
turkey, which contains 2.5 mg CLA/g fat.  The content in seafood ranges from 0.3 to 0.6 
mg CLA/g fat.  Dairy products contain considerable amounts of CLA.  For example, the 
CLA levels in natural cheeses are high and comparable to those in milk (5.5 mg CLA/g 
fat) ranging from 2.9 to 7.1 mg CLA/g fat (Chin and others 1992).  The major isomer of 
CLA, c9t11-C18:2, represents 80-90% of the total CLA in milk fat (Parodi 1977; Chin 
and others 1992) and more than 83% in natural cheeses.  On the other hand, natural 
cheeses that have been aged or ripened have a lower CLA content than unripened ones.  
During ripening of cheese, bacterial enzymes split neutral fat to release free fatty acid 
(including CLA) (Chin and others 1992), which are very vulnerable to further oxidation.  
This fact might indirectly cause decline in the CLA concentration in ripened cheeses. 
9Plant oils contain from 0.1 to 0.7 mg CLA/g fat which is far less CLA than animal 
products.  The two major CLA isomers in plant oils are the c9t11-C18:2 and t10c12-
C18:2, accounting for 43 and 40% respectively.  Processed foods, except for cooked 
meats which tend to be lower in the c9t11-C18:2 isomer, are comparable in CLA content 
to similar unprocessed foods indicating that heat treatment during processing does not 
change total CLA content or c9t11-C18:2 concentration (Chin and others 1992).  In fact 
some processed cheeses present an increased level of total CLA caused by the 
combination of both processing temperatures and the presence of whey components, 
primarily low molecular weight compounds.  Processing temperatures could increase the 
formation of linoleic acid radicals that in the presence of oxygen could lead to either 
conjugated isomers or lipid peroxides.  Lactalbumin and lactoglobulin, the main proteins 
in whey are sources of hydrogen donors (McDermott 1987), thus aiding in the formation 
of conjugated double bonds (Shantha and others 1992).  These proteins may also protect 
against isomerization and oxidation, helping to the stability of CLA during processing 
(Chin and others 1992).
Ocurrence of Conjugated Linoleic Acid in humans
In humans, CLA has been detected mainly in blood, bile, adipose tissue and milk 
(Fogerty and others 1988).  However, CLA also has been found in human cervix because 
of bacterial colonization and activity (Fairbank and others 1989).  The c9t11-C18:2 
isomer represents more than 95% of the conjugated dienes in human tissues (Dormandy 
and Wickens 1987).  In human blood serum, c9t11-C18:2 is associated more with 
triglycerides (58 to 78 %) than with phospholipids (16 to 34 %) or cholesteryl esters (2 to 
10
8 %) (Fogerty and others 1988).  By contrast, Harrison and others (1985) reported a 
similar distribution of CLA among the serum lipids. 
In general, CLA in humans can result from two possible sources:
a) Dietary sources such as ruminant meat and dairy fats contribute to CLA levels in 
human tissues (Jiang and others 1999; MacDonald 2000), human serum and milk 
(Fogerty and others 1988; Britton and others 1992).  Thus fatty acid composition of 
dietary fat can markedly influence the fatty acid composition of blood, lipids and adipose 
tissue (Glatz and others 1989).  The increased CLA levels in plasma and serum in human 
subjects after being supplied with a diet high in CLA support this fact. (Huang and others 
1994; Britton and others 1992).  Studies in rats demonstrate that the incorporation of 
dietary CLA is tissue-dependent, where adipose tissue and lung tissue contain the most 
and brain tissue the least (Sugano and others 1997).  Studies in humans presented a 
similar behavior where a higher average concentration of CLA was found in adipose 
tissue than in serum (Jiang  and others 1999).
b) Endogenous synthesis of CLA in humans may be formed by synthesis from linoleic 
acid in the human organism through anaerobic microbial activity in the large bowel 
(Fogerty and others 1988).  CLA could also be produced in vivo by oxidation of linoleic 
acid to produce free radicals with subsequent diene conjugation.  The conjugated free 
radicals could then react with protein instead of molecular oxygen to form a CLA 
molecule and a protein radical (Cawood and others 1983).  The desaturation of trans-
vaccenic acid by the 9-desaturase as found in rat liver microsomal preparations (Pollard 
and others 1980; Salminen and others 1998) may also lead to endogenous synthesis of 
11
CLA.  Conversion of trans vaccenic acid by the action of intestinal bacteria where CLA 
formed in the colon would be poorly absorbed (Salminen and others 1998). 
Conjugated Linoleic Acid as Antioxidant
In several studies free radicals and radical-mediated oxidation processes have 
been implicated to play an important role in the development of cancer and 
atherosclerosis (Ip 1996).  Antioxidant activity of CLA has been offered as a possible 
explanation for its anticarcinogenic effect (Ha and others 1990) and its role in the 
reduction of atherosclerosis (Lee and others 1994).  However, c9t11-C18:2 was initially 
interpreted as an indicator of free radical attack on polyunsaturated fatty acids 
(Dormandy and Wickens 1987).  Furthermore, in vivo experiments using model 
membranes showed that CLA did not function as an effective antioxidant or antioxidant 
precursor and did not act as an efficient radical scavenger in a manner comparable to -
tocopherol (vitamin E) or butylated hydroxytoluene (BHT) (Van den Berg and others 
1995).  By contrast, previous studies in vitro have revealed that CLA is more resistant to 
oxidation than LA, a more potent antioxidant than vitamin E, and is almost as effective as 
BHT (Ha and others 1990).  Other studies on animals showed that CLA is also able to 
reduce thiobarbituric acid that is a reactive lipid peroxidation product (Ip and others 
1985).  The potent antioxidant activity of CLA (Ha and others 1990; Ip and others 1991) 
may be explained by oxidative modification of CLA into a metal chelator that stops 
radical generation (Ha and others 1990).  However, the mechanisms of potential CLA 
antioxidant activity remains unclear and depends on the conditions under which the 
12
experiments are produced and the reliability of the type of assays that are applied to 
measure lipid oxidation.  
Conjugated Linoleic Acid as Anticarcinogenic.
In general, substances that exhibit anticarcinogenic activity in experimental 
models are mainly from plant origin (Fiala and others 1985; Wattenberg 1992).  The only 
exception found in foods of animal origin is CLA (Fogerty and others 1988; Ha and 
others 1989; Shantha and others 1992).  Although CLA constitutes a relatively minor part 
of the total fatty acid composition of foods, its protective properties against oxidation 
have been related to very low levels in the diet (0.05 % by weight).  Thus, CLA can be 
ingested either as free or as a component fatty acid of triglycerides (Ip and others 1995).
Protective properties against human malignant melanoma, colorectal and human 
breast cancer cells have been shown.  It seems to be more effective than beta-carotene, 
the precursor of vitamin A in this regard (Shultz and others 1992).  However, the 
anticarcinogenic effect of CLA has been somewhat controversial.  Since CLA isomers 
are classified as fatty acids, several studies have revealed that these animal lipids 
(Erickson and Hubbard 1990; Welsch 1992; Welsch 1994; Kondo and others 1994; 
Carrol and Hopkins 1979), especially linoleic acid (Ip and others 1985; Roebuck and 
others 1985), stimulate tumorigenesis in animals.  This is possibly due to fatty acid 
oxidation and lipid peroxidation (Welsch 1987; Fischer and others 1988; Bull and others 
1988).  Hydroxyperoxy and hydroxyl derivatives of linoleic and arachidonic acids 
stimulate DNA synthesis and induce ornithine decarboxylase (ODC) activity.  Both, 
DNA synthesis and ODC activity stimulations are markers of tumor promotion (Bull and 
13
others 1988).  But, mechanism studies indicate that given the structural similarities 
between the two (Pariza and others 2000), CLA may compete with linoleic acid in the 
biosynthesis of arachidonic acid and eicosanoids (Ha and others 1987; Rose and 
Connolly 1990).  Sebedio and others (1997), indicated that, both CLA isomers (c9t11-
and t10c12-C18:2) can be elongated and desaturated in similar ways to that of linoleic 
acid, providing precursors for CLA-derived eicosanoids.  Altered eicosanoid signaling 
and CLA-derived eicosanoid signaling, in particular prostaglandin E2 (PGE2) (Lewis 
1983), could effect a range of biological activities including lipid metabolism and 
cytokine synthesis and function (Pariza 1997).  Cytokines are hormone-like mediators of 
immunity and inflammation that are released by macrophages and other immune cells 
when they are stimulated (Pariza 2000).  Tumor necrosis factor- (TNF-) and 
interleukin-1 (IL-1) are cytokines (Lewis 1983) where TNF- seems to be an important 
mediator in many chronic pathological processes including carcinogenesis (Okahara and 
others 1994; Suganuma and others 1996) and atherosclerosis (Ross 1993).  Thus, the 
inhibition of carcinogenesis by CLA isomers or metabolites could result from the 
combination of different CLA activities such as the effects on eicosanoids (Rose and 
Connolly 1990).  Conjugated linoleic acid can affect prostaglandin metabolism (Liew and 
others 1995; Pariza and others 1999), in particular that of prostaglandin E2 (PGE2) (Li 
and Watkins 1998).  Furthermore, CLA reduces cell proliferation (Belury 2002) by 
blocking DNA synthesis components and cell cycle proteins (Futakuchi and others 2002) 
such as bromodeoxyuridine (BrdU) and cyclins A and D, respectively (Ip and others 
2001).  This increases the tumor suppressor, p53 that induces cell death (apoptosis) 
(Belury 2002).  However, elevated cell death is supported by CLA primarily due to the 
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reduction of Bc1-2 protein that suppresses apoptosis (Belury, 2002).  Conjugated linoleic 
acid affects cell differentiation in animals by reducing the activity of the structures and 
sites where carcinogenic transformation takes place from weaning to adult stage (Ip and 
others 1994).  The direct effect of CLA on vitamin A metabolism may influence cell 
differentiation as well (Banni and others 1999).  The antioxidant property of CLA offers 
significant protection against mammary tumor development by reducing lipid 
peroxidation products found in mammary tissue such as thiobarbituric acid (Ip and others 
1985).  The anticarcinogenic effect of CLA continues to be supported by several different 
studies in vitro and in vivo (Decker 1995; Ip and others 1994; Parodi 1997; Pariza and 
Hargraves 1985). 
Conjugated Linoleic Acid as Antiatherosclerotic
Atherosclerosis is the principal cause of heart attack, stroke and gangrene of the 
extremities, being a strong cause of mortality in the USA, Europe and Japan (Ross 1993).  
For these reasons, efforts have been made to find a cure.  Research on animals has shown 
that a diet based on linoleic acid resulted in dramatic decreases in plasma low-density 
lipoprotein cholesterol (LDL-C) when compared to animals fed with high saturated fat 
diets.  These lipoprotein are greatly associated with reductions in atherosclerosis 
(Hennessy and others 1992).  But, later studies showed that LDL particles enriched with 
linoleic acid are more susceptible to oxidation and presumably more atherogenic than 
oleate-rich diets (Reaven and others 1993; Steinberg and others 1989).  However, several 
studies have shown significant reductions in plasma cholesterol concentrations and 
atherosclerosis in animals fed with CLA when compared with linoleic acid and controls 
15
(Lee and others 1994; Nicolosi and others 1997; Wilson and others 2000).  Nicolosi and 
Laitinen (1996) also reported reduced levels of non-high-density lipoprotein cholesterol 
(combined very-low- and low-density lipoprotein) and triglycerides with no effect on 
high-density lipoprotein cholesterol when hamsters were fed a CLA diet.  Subsequently, 
they also observed that blood lipoproteins do not play an important role in CLA’s 
mechanism of action at least against stroke formation.  Other authors infer that the anti-
atherogenic properties of CLA may be due to an increased plasma tocopherol/total 
cholesterol ratio where CLA may act in place of tocopherol, suggesting a direct or 
indirect antioxidant activity in vivo (Wilson and others 2000).  However, Lee and 
coworkers (1994) suggested that the reduction in aortic atherosclerosis with CLA 
treatment was probably due to alterations in lipoprotein metabolism since oxidative status 
was not significantly altered.  Other studies speculate that CLA might act by altering 
LDL particle size by producing a larger, less atherogenic particle, since small dense LDL 
particles are more susceptible to oxidation (De Graaf and others 1991; Hubel and others 
1998).  Recent studies suggest that the anti-atherosclerotic effect of CLA treatment is not 
due to direct changes in lipoprotein metabolism or LDL oxidation, but possibly through 
other mechanisms such as LDL particle size or LDL lipid composition.  In summary, 
CLA may function through decreased oxidative susceptibility of the LDL via lipid 




Biosynthesis of Bile Salts
Bile acids are synthesized in the liver, stored and concentrated in the gallbladder, 
and then released as salts into the small intestine.  They are the major constituents of bile.  
The precursor of bile salts is cholesterol, which is converted into trihydroxycoprostanoate 
and then into cholyl CoA.  The activated carboxyl carbon of cholyl CoA reacts with the 
amino group of glycine to form the conjugated product named glycocholate, or with the 
amino group of taurine, derived from cysteine, to form taurocholate (Stryer 1995).  
Glycine conjugated bile acids are the major type in human bile due to the minimal 
amount of taurine in the normal diet (Dowling 1972).  However, there are many different 
bile salts that vary characteristically with the species (Lehninger 1972).  Synthesis of 
cholic acid is homeostatically regulated by the amount of bile acids that return to the liver 
through the enterohepatic circulation (Danielsson and Sjovall 1975).
Enterohepatic Circulation of Bile Salts 
In animals, the major pathway of degradation of cholesterol is its conversion to 
bile salts that takes place in the liver.  Bile salts are secreted into the small intestine and 
are largely reabsorbed during lipid absorption.  Thus, the circulation of the bile salts from 
the liver to the small intestine and then to the blood system that goes back to the liver is 
called the enterohepatic circulation (Lehninger 1972).  However bile salts can be 
deconjugated in the intestine due to an intracellular enzyme named bile salt hydrolase 
(BSH) which is found commonly in intestinal species bacteria such as Lactobacillus
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(Gilliland and Speck 1977; Lundeen and Savage 1990). Thus, conjugated bile salts may 
be hydrolyzed to produce the free bile salt (cholate) and the corresponding amino acid 
(Corzo and Gilliland 1999).  The bile salts sodium glycocholate and sodium taurocholate 
give rise to sodium cholate and glycine, and sodium cholate and taurine, respectively.
Absorption of bile salts depends highly on the location in the intestine and the 
type of bile acid being absorbed.  Passive diffusion occurs in all segments of the small 
intestines but in the ileum active transport occurs against an electrochemical gradient 
(Schiff and others 1972).  Molecular charge is important in the absorption of bile salts.  
The pKa of the acids indicate the net charge at a given pH.  The pH of the small intestine 
ranges from 4.5-6.0.  At this pH the deconjugated bile salts (pKa around 6.0) easily 
diffuse in a non-ionic passive diffusion process while the conjugated acids (pKa 2.0-4.0) 
are negatively charged and less well reabsorbed by ionic passive diffusion or much more 
quickly by active transport mechanisms (Dietschy 1968).  As result of these transport 
system, conjugated bile salts are primarily re-absorbed, while most of deconjugated or 
free bile salts are excreted in the feces.
The Role of Bile Salts
Bile salts promote mainly the absorption of lipids (Lehninger 1972).  First, they 
are excreted into the bile and eventually into the intestinal lumen.  Bile salts are highly 
effective emulsifiers because they contain both polar and non-polar regions (Stryer 1995).  
They form micelles with fat-soluble materials that are able to pass through the mucosal 
membranes being absorbed into the body.  Bile salts facilitate digestion and absorption of 
triglycerides, fatty acids, monoglycerides, fat-soluble vitamins, cholesterol, sterols and 
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other fat soluble compounds (Dietschy 1968).  Bile salts that are not absorbed are 
excreted from the body.  Therefore, to maintain the equilibrium in the system, lost bile 
salts are replaced through synthesis from cholesterol (Shimada and others 1969).
Effect of Bile Salts on Lactobacilli
Studies on behavior of lactobacilli in the presence of bile have been narrowed 
down to two aspects, bile resistance and cellular permeability.  Bile resistance is an 
important characteristic of some strains of lactobacilli.  It enables the bacteria to survive, 
to grow and to manifest their action in the small intestines (Walker and Gilliland, 1993).  
At a certain concentration, bile increases cellular permeability, which allows more 
substrate to enter bacteria cells to be transformed by their intracellular enzymes (Noh and 
Gilliland 1993).
Effects of Probiotic Cultures on Health
The beneficial effects of probiotic cultures are many, but only those of major 
relevance will be described in this section.
Probiotic Cultures
Bacteria that provide specific health benefits when consumed as a food 
component or supplement are called probiotics (Guaner and Malagelada 2003).  In other 
words, consumption of probiotics can improve human or animal health.  Among the more 
popular probiotic cultures used are those that mimic the beneficial bacteria already 
present in the human system.  Examples are Lactobacillus acidophilus, followed by 
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Lactobacillus reuteri, different species of Bifidobacterium, Lactobacillus casei, 
Lactobacillus rhamnosis, among others.  However, the level of probiotic bacteria needed 
in food to provide a benefit to the host is still under discussion (Turner 2003).
Lactic Acid Bacteria
Lactic acid bacteria (LAB) refer to a large group of Gram-positive bacteria with 
similar properties that obtain their energy from the production of lactic acid as result of 
carbohydrate fermentation.  These organisms are heterotrophic and frequently have 
complex nutritional requirements because they lack many biosynthetic capabilities.  As 
result, lactic acid bacteria are generally abundant only in communities where these 
requirements can be provided such as animal oral cavities and intestines, plant leaves as 
well as decomposing plant or animal matter.  Lactic acid bacteria of commercial interest 
in the food industry are the genera Lactobacillus, Lactococcus, Leuconostoc, 
Pediococcus and Streptococcus (Daly and others 1998).  Lactic acid bacteria are resistant 
to lysozyme, an enzyme capable of lysing Gram-positive bacteria in the saliva.  They 
reach the intestines to form a layer that adheres to the epithelium, which acts as a defense 
mechanism against invasion of enteropathogenic bacteria (Kasper 1998).  This property 
among others confers to some of them the attribute of being probiotics.  However, it is 
important to mention that not all probiotics are lactic acid bacteria just as all lactic acid 
bacteria are not probiotics. 
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Improved Lactose Utilization by Probiotics
Some people experience cramps, flatulence, and diarrhea after consumption of 
milk products.  This is mainly due to insufficient amounts of the enzyme lactase in the 
small intestines.  This inability to adequately digest lactose can be improved by 
consuming fermented milk with L. acidophilus, a bile resistant bacteria with intracellular 
-galactosidase (an enzyme that breaks down lactose).  Because of its bile resistance 
Lactobacillus. acidophilus colonizes the small intestines and at the same time produces 
additional amounts of the enzyme.  This is a clear advantage over traditional yogurt 
starter cultures, which usually die before reaching the small intestines (Gilliland 1990).
Control of Intestinal Infections by Probiotics
Gastrointestinal infections and their consequences are a major clinical problem 
(Kasper 1998) due to frequent colonization of the gastrointestinal tract by pathogens such 
as Clostridium difficile, Salmonella typhimurium, Escherichia coli and Shigella sonnei
(Cross 2002).  As a consequence, a wide range of antibiotics has been used over the years 
developing resistant strains (Kasper 1998).  In search of therapeutic improvements, 
probiotics have taken the challenge due to their properties.  Among them, L. acidophilus
has been successful in the treatment of diarrhea, mucous colitis, and antibiotic colitis 
(Gililland 1990).  The modes of action by which probiotics exert relief are not well 
defined.  However these microorganisms exhibit some inhibitory activity against 
pathogen growth by producing localized organic acids (acetic and lactic acid), hydrogen 
peroxide and several antibiotic-like compounds (Kasper 1998) such as acidolin, 
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acidophilin, lactocidin and bacteriocins (Gilliland 1990).  Probiotics also can limit 
pathogen attachment by means of competitive exclusion because they seed the gut 
mucosa reducing the space for pathogens to grow (Cross 2002).  These friendly bacteria 
may even reduce more pathogen adhesion to surfaces by producing biosurfactants (Reid 
and others 1998).  Immunomodulatory signals produced by probiotics influence the 
immune system at the local and systemic level.  Some strains of lactobacilli can directly 
stimulate the immune system by increasing lymphocyte populations and cell surface 
receptor expression in the gut tissue (Cross 2002).  Some strains of lactobacilli can 
translocate across the intestinal mucosa (without infection) to enter circulation via 
lymphatic drainage and thoracic duct channeling and interact with leucocytes (white 
blood cells).  Once in contact with leucocytes of host, Gram-positive bacteria transduce 
signals given by the pathogens.  As response, the host releases pro-inflammatory 
cytokines called neutrophiles and macrophages to fight against infection (Cross 2002).
Effects of Probiotics on Cancer
Environmental factors such as diet have a major role in the development of 
sporadic colon cancer.  High intake of red meat is associated with high risk of colon 
cancer while fruits and vegetables are associated with reduced risk (Guarner and 
Malagelada 2003).  The effect of diet could be mediated by modifying the metabolic 
activity and the composition of the gastrointestinal microflora.  The ingestion of 
Lactobacillus acidophilus has proven to bind mutagenic heterocyclic amines formed by 
cooking protein-rich food (Orrhage and others 1994).  Lactic acid bacteria such as 
Lactobacillus casei can significantly decrease the specific activity of -glucuronidase, 
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nitroreductase and azoreductase which are enzymes that transform procarcinogens to the 
active form (Kasper 1998).  In a human study, daily intake of lyophilized L. acidophilus 
for three months significantly reduced cell division in the upper part of the colonic crypts 
(Biasco and others 1991).  Increased cell division activity in the upper part of the crypts 
is considered a pre-neoplastic stage (Kasper 1998).  Usually, the evidence for the anti-
tumorigenic activities of lactic acid bacteria in humans is indirect (Daly and others 1998).  
However, Aso and others (1992, 1995) showed that oral administration of L. casei 
Shirota strain reduces the recurrence of a superficial bladder carcinoma in humans.  
Although the mechanism whereby lactic acid bacteria produce anti-tumor activity is not 
clear (Gilliland 1990), many of these organisms produce butyrate or butyric acid as a 
metabolic end product (Daly and others 1998). This fatty acid has been shown to inhibit 
tumorigenic growth in vitro (Young 1996).  Other reports suggest that the antitumor 
activity extracted from cells of Lactobacillus delbrueckii ssp. bulgaricus was due to 
glycopeptides (Bogdanov and others 1975).  Production of the anticarcinogenic CLA has 
been claimed by some strains of lactobacilli such as Lactobacillus reuteri (Pariza and 
Yang 1998).  This topic is described in a previous section of this literature review (CLA 
and its benefits). In general, lactobacilli capable of growing in the human intestinal tract 
may provide a greater chance for producing antitumor activities than those organisms 
unable to survive and grow in this environment (Gilliland 1990).
Effects of Probiotics on Serum Cholesterol
The hypocholesterolemic action of Lactobacillus species was first noticed when
the consumption of cultured or culture containing dairy products supplemented with 
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certain strains of L. acidophilus reduced concentrations of serum cholesterol (Gilliland 
1990).  These lactobacilli were grown under laboratory conditions such as anaerobiosis 
and in the presence of bile salts, both of which occur in the small intestines, to see if they 
could assimilate cholesterol (Noh and Gilliland 1993).  Since lactobacilli had success in 
vitro, studies were prepared in vivo with pigs fed a diet high in cholesterol and 
supplemented with a strain of L. acidophilus that efficiently assimilated cholesterol from 
the laboratory study.  Successfully, the strain of L. acidophilus was able to lower serum 
cholesterol of pigs (Gilliland and others 1985).  A similar study conducted by another 
group of researchers supported the fact that L. acidophilus may lower cholesterol levels 
in vivo (Danielson and others 1989).  The hypocholesterolemic action of the lactobacilli 
might be explained by their ability to deconjugate the bile salts (Gilliland and Speck 
1977) and to incorporate some cholesterol into the cellular membrane (Noh and others 
1997).  However, a later study on cholesterol removal from broth by Brashears and others 
(1998) indicated that most of the cholesterol removal by strains of L. acidophilus was due 
to assimilation, perhaps by incorporating cholesterol into the cellular membrane, while 
strains of L. casei most likely remove cholesterol by destabilization of cholesterol 
micelles and coprecipitation of cholesterol with deconjugated bile salts at pH less than 
6.0.  Nevertheless, how could bile acid deconjugation and cholesterol incorporation 
decrease cholesterol levels in the human body?  Deconjugated bile acids do not function 
as well as the conjugated ones in the intestinal absorption of cholesterol (Eyssen 1973).  
Deconjugated bile salts are less likely to be reabsorbed from the intestines (Chikai and 
others 1987).  Increased deconjugation of bile salts could result in greater excretion of 
free bile salts from the intestinal tract (Chikai and others 1987), stimulating the synthesis 
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of their replacement from cholesterol (De Rodas and others 1996).  Furthermore, free bile 
salts do not support the absorption of lipids, including cholesterol, from the intestines 
(Dietschy and Wilson 1970; Playoust and Isselbacher 1964).  Thus, both effects, the use 
of cholesterol to produce de novo bile salts and the interrupted absorption of cholesterol 
from the intestines may reduce serum cholesterol levels in the body (Brashears and others 
1998; De Rodas and others 1996).  Strains of lactobacilli that prefer to deconjugate 
sodium glycocholate, the main bile salt in the human intestinal tract, better than sodium 
taurocholate may be more relevant to lower serum cholesterol (Brashears and others 
1998).  Lactobacillus acidophilus, L. casei (Corzo and Gilliland, 1999) and L. reuteri
(Taranto and others 1999) deconjugate bile acids during growth by action of the enzyme 
bile salt hydrolase.  Lactobacilli deconjugate bile salts the best in the late exponential 
phase (Walker and Gilliland, 1993) and at pH of approximately 6.0 (Gilliland and Speck, 
1977).  Cholesterol incorporated into or adhered to the bacterial cells would be less 
available for absorption from the intestine into the blood (Brashears and others 1998).  
The maximum assimilation of cholesterol by lactobacilli occurs in the late exponential 
phase of growth (Walker and Gilliland 1993).  The assimilation of cholesterol by L. 
acidophilus requires growth under anaerobic conditions and the presence of bile salts.  
However the most bile-tolerant lactobacilli strains may not necessarily assimilate the 
most cholesterol, furthermore their ability to assimilate cholesterol varies among strains 
(Gilliland et al., 1985).  Studies on the antiatherosclerotic effect of CLA, a compound 
produced by some lactobacilli has caught the attention of researchers.  How the 
compound is produced and its beneficial effects are better described in a previous section 
of this literature review (CLA and its benefits).  In brief, any mechanism, bile salt 
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deconjugation, cholesterol incorporation or CLA production is important in controlling 
serum cholesterol concentrations in humans.
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CHAPTER III
INFLUENCE OF GLYCOCHOLIC ACID ON PRODUCTION OF CONJUGATED 
LINOLEIC ACID BY CELLS OF LACTOBACILLUS REUTERI 55739
Mireya Roman-Nunez and Stanley E. Gilliland




Cells of L. reuteri 55739 grown in MRS broth with and without linoleic acid (LA, 
0.2%) were harvested and washed.  The washed cells were added to buffer containing LA 
(0.2%) and incubated 18 h at 37 °C.  The cells, which had been grown without LA, 
transformed LA into conjugated linoleic acid (CLA, mainly c9t11-C18:2) better than did 
those cells grown with it.  When glycocholic acid (0.3%) was added to the washed cell 
suspension about the same levels of CLA was formed regardless of whether or not the 
cells had been grown in the presence of glycocholic acid.  
Introduction
Conjugated linoleic acid (CLA) refers to a group of positional and geometric 
isomers of linoleic acid (LA; c9c12-C18:2) (MacDonald 2000).  The major isomer, c9t11 
octadecadienoic acid (Kepler and Tove 1967), has been suggested to be antioxidative 
(Pariza 1991), anticarcinogenic (Pariza and Hargraves 1985; Pariza 1991), and 
antiatherosclerotic (Lee and others 1994; Wilson and others 2000) 
Conjugated linoleic acid is produced by chemical synthesis (Christie and others 
1997), by rumen bacteria (Bauman and others 1999) or by lactic acid bacteria (LAB) 
(Ogawa and others 2001).  Among LAB the genus Lactobacillus has gained recent 
attention because they can control cancer (Kasper 1998) and lower serum cholesterol 
(Gilliland 1990).
Lactobacillus reuteri, a probiotic that highly effectively enzymatically transforms 
LA into CLA (Pariza and Yang 1998), is also bile resistant (De Boever and others 2000).  
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This is an important property for its survival and establishment in the intestinal tract 
(Gilliland 1990). 
Exposure to bile acids has shown to modify cell permeability of L. reuteri
(Taranto and others 2003).  Therefore since linoleate isomerase, the enzyme responsible 
for CLA production is intracellular (Pariza and Yang 1996), it may be that the presence 
of glycocholic acid, a major bile acid (Brashears and others 1998) could improve its 
performance.  The purpose of this study was to investigate the influence of glycocholic 
acid on CLA production by L. reuteri 55739.
Material and Methods
Source and Maintenance of Cultures
The culture used in this study, Lactobacillus reuteri 55739, was purchased from 
the American Type Culture Collection (Manassas, VA., U.S.A.). 
The culture was activated before experimentation by subculturing three times just 
prior to use in lactobacilli Man Rogosa and Sharpe (MRS) broth made according to the 
manufacturer’s directions (Difco Laboratories, Detroit, MI., U.S.A.).  The MRS broth 
was inoculated (1%) and incubated for 18 h at 37 °C.  The culture was kept at 4 °C 
between transfers. 
Enumeration of Lactobacilli
The number of lactobacilli in the samples was determined using the pour plate 
method on MRS agar (Vanderzant and Splittstoesser 1992) and expressed as colony 
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forming units (CFU) per milliliter.  Dilution blanks containing 99 mL of sterilized 
solution of 0.1% peptone (Difco Laboratories, Detroit, MI., U.S.A.) were used.  After 
pouring plates, they were overlayed with about 5 mL MRS agar and incubated at 37 °C.  
At 48 h all visible colonies were counted and recorded.
Conjugated Linoleic Acid Production and Linoleic acid/Conjugated Linoleic Acid
Incorporation by L.reuteri 55739
Cells of L. reuteri (1% inoculation) were grown at 37 °C in 10 mL tubes 
containing MRS supplemented with 0.2% linoleic acid (Matreya, State College, PA., 
U.S.A) added as aqueous solution in 1% v/v Tween 80 (Sigma Chemical Co., St. Louis, 
MO., U.S.A.).  A control tube was prepared with MRS broth containing 0.2% linoleic 
acid without cells.  The cells were harvested by centrifugation (12000 x g for 10 min at 2 
to 4 °C) in a Sorvall RC-5 centrifuge (DuPont Co., Newton, CT., U.S.A.) at 0 h and 24 h 
of incubation time.  The cell pellet was resuspended in 1 mL saline solution (0.137 mol/L 
NaCl, 7.0 mmol/L K2HPO4 and 2.5 mmol/L KH2PO4).  Lipid extraction was performed 
on the control, the cell free supernatants as well as the pellets.
Influence of Concentrations of Linoleic Acid on Conjugated Linoleic Acid Production by 
Washed Cells
Cells of L. reuteri 55739 (1% inoculation) were grown at 37 °C in 50 mL MRS 
broth.  After 18 h the cells were harvested by centrifugation (12000 x g for 10 min at 2 to 
4 °C), washed with 50 mL of cold 0.05 M sodium phosphate buffer (pH 7.0) and 
resuspended in 45 mL of the same buffer.  The washed cells were dispensed in 9 mL 
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volumes into 5 test tubes. A control set of 5 tubes was prepared with 9 mL volumes of 
cold 0.05 M sodium phosphate buffer (pH 7.0) without cells.  A 1 mL aliquot of linoleic 
acid stock solution 0.10%, 0.15%, 0.20%, 0.25% and 0.30% in 1% v/v Tween 80 was 
added to tube 1 thru 5 of each set to obtain a final concentration of linoleic acid from 0.10 
thru 0.30 mg/mL respectively. All tubes were incubated at 37 °C for 18 h. After 
incubation the contents of each tube were centrifuged (12000 x g for 10 min at 2 to 4 °C) 
and clear supernatants were collected for analysis.
Effect of Sonication on Conjugated Linoleic Acid Production by Washed Cells 
Lactobacillus reuteri 55739 (1% inoculation) was grown at 37 °C in 40 mL MRS.  
After 18 h the cells were harvested and washed as described above and resuspended in 40 
mL of the same buffer containing linoleic acid (0.2%).  They were dispensed in 10 mL 
volumes into test tubes.  The contents of two tubes were sonicated at power 4 for 30 min 
using Branson sonicator (Branson Ultrasonics Corp., Danbury, CT., U.S.A.), while 2 
other tubes were not.  Once sonicated, viable cell count was determined in one tube of 
each set using the pour plate method.  The remaining tubes were incubated at 37 °C for 
18 h after which the contents of each tube were centrifuged (12000 x g for 10 min at 2 to 
4 °C) and clear supernatants were collected for analysis.
Influence of Glycocholic Acid on Conjugated Linoleic Acid  Production by Washed Cells 
Cells of L. reuteri 55739 (1% inoculation) were grown at 37 °C in 20 mL MRS 
broth with and without 0.2% linoleic acid added as aqueous solution in 1% v/v Tween 80.  
After 18 h the cells were harvested by centrifugation (12000 x g for 10 min at 2 to 4 °C).  
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The cells from each media were washed with 20 mL of cold 0.05 M sodium phosphate 
buffer (pH 7.0), resuspended in 20 mL of the same buffer containing linoleic acid (0.2%) 
and dispensed in 10 mL volumes into test tubes.  A control set of 2 tubes was prepared by 
dispensing 10 mL volumes of 0.05 M sodium phosphate buffer (pH 7.0) with linoleic 
acid (0.2%) without washed cells. To investigate the effect of glycocholic acid on CLA 
production, 1 mL of 3.0% aqueous glycocholic acid (Sigma Chemical Co., St. Louis, 
MO., U.S.A.) was added to each tube.  All tubes were incubated at 37 °C for 18 h. After 
incubation the contents of each tube were centrifuged (12000 x g for 10 min at 2 to 4 °C) 
and clear supernatants collected for lipid extraction procedure.
Lipid Extraction from Cell Free Supernatants
This method is based on that of Alonso and others (2003). First, a 6 mL volume of 
spent broth or uninoculated broth or supernatant from washed cells was mixed with 60 
µL of heptadecanoic acid solution (Sigma Chemical Co., St. Louis, MO., U.S.A.), used as 
internal standard (64.4 mg of heptadecanoic in 10 mL of hexane).  Then 12 mL of 
isopropanol (Pharmaco Products Inc., Brookfield, CT., U.S.A.) were added and shaken 
vigorously, followed by 9 mL of hexane (Pharmaco Products Inc., Brookfield, CT., 
U.S.A.).  The mixture was shaken 3 min before centrifugation at 1910 x g for 5 min at 2 
to 4 °C.  The supernatant was collected and filtered through approximately 5.0 g dry 
sodium sulphate (Spectrum Quality Products Inc., Gardena, CA., U.S.A.); 7 mL of 
hexane were used to wash the sodium sulphate.  The lipid fraction of the sample thus 
obtained was placed into a 25-mL pear-shaped flask, and dried under nitrogen gas at 70 
°C in a Zymark Turbo Vap LV evaporator (Zymark Corp., Hopkinton, MA., U.S.A.).  
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The dried sample was redisolved with 500 µL hexane and transferred to a microtube.  
The extracted lipid fraction was mixed with 100 µL 1 N methanolic sodium hydroxide 
(Spectrum Quality Products Inc., Gardena, CA., U.S.A), then vortexed for 1 min and held 
at 70 °C in a water bath for 15 min. At this point the samples are ready to prepare fatty 
acid methyl esters.
Lipid Extraction from Bacterial Pellet
The CLA analysis for bacterial pellet samples was modified from Coakley and 
others (2003) where 60 µL of internal standard (6.49 mg/mL heptadecanoic acid in 
hexane) were added to the pellet suspended in 1 mL saline solution (0.137 mol/L NaCl, 
7.0 mmol/L K2HPO4 and 2.5 mmol/L KH2PO4).  Then 2 mL of isopropanol were added 
and vortexed 60 seconds followed by the incorporation of 1.5 mL of hexane.  The 
mixture was shaken vigorously for 3 min and centrifuged 5 min at 1910 x g at 2 to 4 °C. 
The upper layer was recovered and dried under nitrogen gas at 70°C for 10 min in the 
Zymark evaporator.  The sample was dissolved in 500 µL hexane and transferred to a 
microtube where a 100 µL 1N methanolic sodium hydroxide were added and vortexed 1 
min.  The mixture was hold 15 min in a 70 °C bath. Then fatty acid methyl esters were 
prepared.
Preparation of Fatty Acid Methyl Ester
Methylation of free fatty acids in the mixture from extracted lipids from cell free 
supernatants as well as cell pellets was achieved by adding 200 µL of 14% boron 
trifluoride in methanol (Sigma Chemical Co. St. Lous, MO., U.S.A.) and holding it at 
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room temperature for 30 min.  Then 200 µL of hexane and 100 µL of deionized water 
were added, the samples were vortexed thoroughly, and centrifuged in a refrigerated 
microcentrifuge SFR13K-120 (Savant Instruments Inc., Farmingdale, N.Y., U.S.A.) at 
2000 x g for 3 min.  The upper layer was recovered and stored in a vial at –20 °C, until 
further analyses by gas chromatography.
Gas Chromatography Analyses
All gas chromatography analyses were performed on a HP6890 gas liquid 
chromatograph (Hewlett-Packard, Wilmington, DE., U.S.A.), equipped with a split/ 
splitless injector and flame ionization detector (FID).  The fatty acid methyl esters were 
separated on a CP Sil 88 column (100 m x 0.25 mm i.d) containing 100% cyanopropyl 
siloxane stationary phase, 0.20 µm film thickness (Chrompack, Varian, Inc., CA., 
U.S.A).  Helium (28 psi, 1.97 kg/cm2) was used as the carrier gas with a split ratio of 
1:50.  The conditions used were 190 °C isothermal temperature, 250 °C injector 
temperature, and 250 °C detector temperature.  The amount injected was 2 µL, and the 
peak of the c9t11 -C18:2 isomer was identified by comparison with the retention times of 
the reference standard (Matreya, Inc., State College, PA., U.S.A.).  The amounts of c9t11 
-C18:2 isomer were calculated as µg CLA/mL culture based on the areas of individual 
CLA and the internal standard peaks.
Statistical Analyses
Experiments were conducted in triplicate or quadruplicate.  Each value was the 
mean of three or four independent trials.  Data were analyzed using SAS (SAS Inst. 
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2001) as a randomized block design.  Least significant difference analyses and Tukey’s 
test were used to compare means.  Significant differences were determined at P<0.05 
(Steel and others 1997).
Results and Discussion
Confirmation of Identity of L. reuteri 55739
The identity of L. reuteri 55739 in this study was confirmed (Appendix A).  The 
identity characteristics of the strain were similar to those listed for this organism in 
Bergey’s Manual of Systemic Bacteriology (Sneath and others 1986).  The strain of 
lactobacilli used in this study matched the published reactions except for arabinose, 
gluconate and ribose.
Conjugated Linoleic Acid Production and Linoleic acid/Conjugated Linoleic Acid  
Incorporation by L.reuteri 55739
The CLA produced by cultures of lactobacilli is mainly found in the extracellular 
phase (Jiang and others 1998), however it can also occur in the cellular membrane when 
the organism is grown in the presence of exogenous linoleic acid (Jenkins and Courtney 
2003).  In this study the ability to produce CLA by L. reuteri 55739 was confirmed, it
was primarily exogenous CLA (mainly c9t11-C18:2) as mention by Pariza and Yang 
(1998).  After 24 h incubation the mean cell concentration was 1.9x109 CFU/mL.
However, when the incorporation of linoleic acid or CLA into cell membrane was 
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checked, the results showed no significant incorporation of either compound. Linoleic 
acid that was not transformed into CLA appeared to remain in the broth (Table 1).  
Table 1–Conjugated linoleic acid production and LA/CLA 
incorporation by L. reuteri 55739
Fatty Acids (µg/mL)1
Incubation (h) LA2 CLA3
Supernatant 0 205.49a 0.00b
Supernatant 24 88.29b 118.75a
Cell pellet 0 0.00c 0.00c
Cell pellet 24 0.00c 3.06c
abcMeans in the same column for the supernatant and for the cell pellet with 
                     different superscripts differ (P<0.05)
1Data are the means from 3 experiments
2LA, linoleic acid; supernatant values compared against control 224.18a µg/mL
3CLA, conjugated linoleic acid (c9t11-C18:2); supernatant values compared 
                      against control 0.00b µg/mL
Influence of Concentrations of Linoleic Acid on Conjugated Linoleic Acid Production by 
Washed Cells
The amounts of CLA (c9t11-C18:2) formed by washed cells previously grown in 
MRS without linoleic acid was nearly constant when the added amount of free linoleic 
acid in the buffer was between 0.15 and 0.30%.  However, there was a significant 
increase between buffer containing 0.10 and 0.15% linoleic acid (Table 2).  Studies by 
Jiang and others (1998) found that the formation of CLA during growth by 
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propionibacteria was related to the amount of linoleic acid in the medium up to 0.20%, 
between 0.20 and 0.60% the production remained almost constant.  In another report 
0.20% linoleic acid added to MRS broth resulted in production of more CLA after 24 h 
incubation time than in broth containing 0.4% by active strains of lactobacilli (Alonso 
and others 2003).  Thus, based on the observations found in this experiment and the 
literature review, it was recommended to add 0.20% linoleic acid to media in future 
experiments with washed cells.
Table 2–Influence of concentrations of linoleic acid on CLA production
         by washed cells of L. retueri 55739 at 18 h
Fatty Acids (µg/mL)1 Conversion (%)
Growth media2 LA3 (%) LA4 CLA5 LA into CLA6
MRS 0.10 17.27e 48.74b 70
MRS 0.15 52.76d 65.51a 70
MRS 0.20 75.34c 66.65a 60
MRS 0.25 105.88b 60.18ab 50
MRS 0.30 150.89a 73.69a 40
abcdeMeans in the same column with same superscripts do not differ (P>0.05)
1Data are the means from 3 experiments
                2MRS, Man Rogosa and Sharpe broth
                3Added amount of linoleic acid
                4LA, linoleic acid detected in supernatant; values compared against control 68.67, 92.44, 
           121.32, 127.52 and 211.28 µg/mL for 0.1 thru 0.3% LA respectively
                5CLA, conjugated linoleic acid (c9t11-C18:2) detected in supernatant; values compared 
          against control 0.00 µg/mL for 0.1 thru 0.3% linoleic acid
6Conversion values based on those of control
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Effect of Sonication on Conjugated Linoleic Acid Production by Washed Cells 
Cell viability of washed cells of L. reuteri 55739 was compromised when 
sonication was applied.  Washed cells that were sonicated showed a much lower plate 
count (mean 1.2x108 CFU/mL) than those that were not (mean 1.6x109 CFU/mL).  A 
decrease in the viable cell count is related to disruption of cells and release of 
endoenzymes (Wang and Sakakibara 1997).  However, when CLA production was 
measured non-sonicated cells transformed more free linoleic acid than did the sonicated 
ones (Table 3).  This implies that although cells of L. reuteri 55739 were disrupted by 
sonication, linoleate isomerase (bound membrane enzyme responsible for CLA 
production) was not effectively released or was inactivated.  
Table 3–Effect of sonication on CLA production





abMeans in the same column with different superscripts 
                                    differ (P<0.05)
1Data are the means from 3 experiments
                                                       2LA, linoleic acid detected in supernatant
                                                       3CLA, conjugated linoleic acid (c9t11-C18:2) detected in 
                                   supernatant
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Influence of Glycocholic Acid on Conjugated Linoleic Acid Production by Washed Cells
A study on L. acidophilus found that cells previously grown in medium 
containing LA had a higher CLA productivity that those cells grown in medium without 
LA (Ogawa and others 2001).  However, in the present study, washed cells of L reuteri
55739 previously grown without LA (mean 1.1x109 CFU/mL) produced more CLA 
(c9t11-C18:2) than did those cells previously grown with LA (1.6x109 CFU/mL).  An 
explanation would be that washed cells of L. reuteri previously grown on LA are less 
active than unexposed washed cells in converting LA into CLA (Lee and others 2003).  
When glycocholic acid was added to washed cells, CLA production was not significantly 
higher than in its absence (Table 2).  Because L. reuteri grows in the presence of 0.3% 
oxgall, a bile salt (Taranto and others 2003), it is not expected to lyse in the presence of 
0.3% glycocholic acid.  However, 0.3% bile salt can alter the permeability of cells of 
lactobacilli (Noh and Gilliland 1993).
Bile salts can produce folds and buds in the cell membrane of L. reuteri, which 
normally exhibits a flat and disorganized distribution (Valdez and others 1996).  These 
changes may not only affect cell permeability but also the interactions between the 
membrane and the surroundings (Taranto and others 2003).  As consequence, it is 
possible that the whole intracellular enzyme system of L. reuteri could be affected by the 
presence of bile. Some compounds such as acidic phenols once inside the cells of L. 
plantarum inhibit some fatty acid-metabolizing enzymes (Rozes and Peres 1998).  The 
presence of bile salts during growth produced an increase in some unsaturated fatty acids, 
but a decrease in cyclic fatty acids in L. reuteri (Taranto and others 2003).  However, 
when the properties of linoleate isomerase were examined, the enzyme did not require 
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addition of external cofactors or energy (Peng and others 2003).  In fact, experiments 
performed by Rosson and others (1999) indicate that the concentration of Tween 80 
seemed to affect linoleate isomerase activity the most among other components of the 
medium such as yeast extract, peptone, acetate, glucose, salts and vitamins. 
                  Table 4–Effect of glycocholic acid on CLA production by 
                  washed cells of L. reuteri 55739 resuspended in 0.05 M sodium
                  phosphate buffer (pH 7.0) with LA (0.2%) at 18 h
Fatty Acids (µg/mL)1
Growth media2 GA3 LA4 CLA5
MRS - 29.84b 59.56a
MRS + 33.48b 64.28a
MRS-LA - 60.84a 28.79b
MRS-LA + 68.70a 25.98b
abMeans in the same column with different superscripts differ (P<0.05)
1Data are the means from 4 experiments
                                 2MRS, washed cells grown in Man Rogosa and Sharpe broth; MRS-LA, 
                     washed cells grown in MRS broth with 0.2% linoleic acid
          3GA, 0.3% glycocholic acid; (-) no exposure to, (+) exposure to
          4LA, linoleic acid detected in supernatant from washed cells; values compared 
       against those from control (uninoculated 0.05 M sodium phosphate buffer) 
       with and without GA added, 101.27 µg/mL and 97.01µg/mL respectively
          5CLA, conjugated linoleic acid (c9t11-C18:2) detected in supernatant from 
       washed cells; values compared against those from control (uninoculated 
       0.05 M sodium phosphate buffer) with and without GA added, 0.00µg/mL and
       0.00µg/mL respectively
Thus, in this study it may be that bile salts simply display no effect on linoleate 
isomerase, the enzyme responsible for converting LA into CLA.  Therefore no noticeable 
increase in CLA production was observed when washed cells were exposed to GA.  
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Further studies are needed to elucidate how LA conversion into CLA by L reuteri could 
be improved.
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APPENDIX A
IDENTITY OF LACTOBACILLUS REUTERI 55739
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                     Table 5–Identity characteristics of Lactobacillus reuteri 55739
























Gram stain + +
Morphology Rod Rod
Growth at 45 °C + +
Growth at 15 °C - -
    1Lactobacillus reuteri reactions as listed in the 9th edition of Bergey’s 





Table 6–Conjugated linoleic acid production and LA/CLA incorpora-
tion by L. retueri 55739, raw data.
Fatty Acids (µg/mL)
Incubation (h) LA1 CLA2
Experiment 1 Supernatant 0 222.03 0.00
Supernatant 24 88.57 123.44
Cell pellet 0 0.00 0.00
Cell pellet 24 0.00 3.07
Experiment 2 Supernatant 0 212.44 0.00
Supernatant 24 77.45 103.96
Cell pellet 0 0.00 0.00
Cell pellet 24 0.00 3.31
Experiment 3 Supernatant 0 182.00 0.00
Supernatant 24 98.84 128.84
Cell pellet 0 0.00 0.00
Cell pellet 24 0.00 2.80
1LA, linoleic acid; supernatant values compared against control 225.55, 194.86, and 
224.18µg/mL for experiments 1 thru 3 respectively
                2CLA, conjugated linoleic acid (c9t11-C18:2); supernatant values compared against con-
           trol 0.00µg/mL for experiments 1thru 3
Table 7–Lactobacillus reuteri 55739 growth in Man Rogosa and 
         Sharpe broth with 0.2 mg/mL linoleic acid
Plate counts (CFU/mL)1
Incubation (h) Exp 1 Exp 2 Exp 3 Mean
0 1.7x108 1.5x108 1.5x108 1.6x108b 
24 2.0x109 2.2x109 1.6x109 1.9x109a 
abMeans in the same column with different superscripts differ (P<0.05)
                1Colony formit units per milliliter
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Table 8–Influence of concentrations of linoleic acid on CLA
production by washed cells of L. retueri 55739 at 18h, raw data
Fatty Acids (µg/mL)
Media1 LA2 (%) LA3 CLA4
Experiment 1 MRS-C 0.10 79.31 0.00
MRS-C 0.15 90.26 0.00
MRS-C 0.20 117.33 0.00
MRS-C 0.25 * 0.00
MRS-C 0.30 238.97 0.00
MRS 0.10 16.73 43.67
MRS 0.15 51.95 64.98
MRS 0.20 70.44 70.08
MRS 0.25 111.39 47.43
MRS 0.30 152.64 76.36
Experiment 2 MRS-C 0.10 74.44 0.00
MRS-C 0.15 91.97 0.00
MRS-C 0.20 109.25 0.00
MRS-C 0.25 129.51 0.00
MRS-C 0.30 211.40 0.00
MRS 0.10 14.86 53.86
MRS 0.15 53.74 64.53
MRS 0.20 80.48 63.79
MRS 0.25 101.20 67.62
MRS 0.30 159.63 73.10
Experiment 3 MRS-C 0.10 52.27 0.00
MRS-C 0.15 95.09 0.00
MRS-C 0.20 137.37 0.00
MRS-C 0.25 125.53 0.00
MRS-C 0.30 183.47 0.00
MRS 0.10 20.23 48.69
MRS 0.15 52.60 67.01
MRS 0.20 75.11 66.09
MRS 0.25 105.04 65.48
MRS 0.30 140.41 71.60
        1MRS, Man Rogosa and Sharpe broth; MRS-C, MRS uninoculated control
                      2Added amount of linoleic acid
                      3LA, linoleic acid detected in supernatant
                     4CLA, conjugated linoleic acid (c9t11-C18:2) detected in supernatant
              *Loss value
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Table 9–Lactobacillus reuteri 55739 initial biomass added to MRS medium
      with different linoleic acid concentrations at 0 h
Plate counts (CFU/mL)3
Growh media1 Content2 (%) Exp 1 Exp 2 Exp 3 Mean4
MRS 0.10 1.8x109 1.5x109 8.6x108 1.4x109a 
MRS 0.15 1.4x109 1.8x109 6.5x108 1.3x109a 
MRS 0.20 1.4x109 2.0x109 9.8x108 1.5x109a 
MRS 0.25 1.0x109 2.1x109 1.1x109 1.4x109a 
MRS 0.30 9.5x108 1.7x109 7.0x108 1.1x109a 
aMeans in the same column with different superscripts differ (P<0.05)
           1MRS, Man Rogosa and Sharpe broth
           2Amount of linoleic acid added to media
           3Colony formit units per milliliter
4The mean value for all initial biomass values is 1.3x109 CFU/mL
Table 10–Effect of sonication on CLA production by 
                     washed cells of L. retueri 55739 at 18 h, raw data
Fatty Acids (µg/mL)
LA1 CLA2
Experiment 1 Non-sonication 133.84 23.18
Sonication 157.24 1.74
Experiment 2 Non-sonication 123.49 15.20
Sonication 150.51 0.00
Experiment 3 Non-sonication 116.95 31.57
Sonication 154.18 0.00
                                       1LA, linoleic acid detected in supernatant
                                       2CLA, conjugated linoleic acid (c9t11-C18:2) detected in supernatant
Table 11–Effect of sonication on cell viability of L. retueri 55739
Plate counts (CFU/mL)1
Cells Exp 1 Exp 2 Exp 3 Mean
Non-Sonicated 1.8x109 1.4x109 1.6x109 1.6x109a 
Sonicated 1.1x108 1.4x108 1.0x108 1.2x108b 
aMeans in the same column with different superscripts differ (P<0.05)
                      1Colony formit units per milliliter
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            Table 12–Effect of glycocholic acid on CLA production by washed 
            cells of L.  reuteri 55739 resuspended in 0.05 M sodium phosphate
            buffer (pH 7.0) with LA (0.2%) at 18h, raw data
Fatty Acids (µg/mL)
Growth medium1 GAb LAc CLAd
Experiment 1 MRS - 29.68 56.93
MRS + 27.52 51.94
MRS-LA - 55.17 24.41
MRS-LA + 56.23 27.67
Experiment 2 MRS - 35.99 38.23
MRS + 41.24 37.49
MRS-LA - 64.55 10.82
MRS-LA + 76.98 9.27
Experiment 3 MRS - 28.00 41.67
MRS + 29.18 42.83
MRS-LA - 42.51 20.53
MRS-LA + 63.49 15.27
Experiment 4 MRS - 25.70 101.40
MRS + 35.97 124.88
MRS-LA - 81.14 59.40
MRS-LA + 78.12 51.71
1MRS, washed cells grown in Man Rogosa and Sharpe broth; MRS-LA, washed cells 
grown in MRS broth with 0.2% linoleic acid
bGA, 0.3% glycocholic acid; (-) no exposure to, (+) exposure to
cLA, linoleic acid detected in supernatant from washed cells; values compared against
those from control (uninoculated 0.05 M sodium phosphate buffer) with (82.20, 83.50, 
82.06 and 157.32 µg/mL) and without (84.64, 88.03, 95.53, and 119.63µg/mL) 
GA added, experiments 1 thru 4 respectively
dCLA, conjugated linoleic acid (c9t11-C18:2) detected in supernatant from washed 
cells;  values compared against those from control (uninoculated 0.05 M sodium phos-
phate buffer) with (0.00µg/mL) and without (0.00µg/mL) GA added, experiments 1 thru
4 respectively
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Table 13–Cells of L. reuteri 55739 added to 0.05 M sodium phosphate buffer 
(pH 7.0) with LA (0.2%) at 0 h
Plate counts (CFU/mL) d
Growth mediab GAc Exp 1 Exp 2 Exp 3 Exp 4 Meane
MRS - 1.1 x109 9.2x108 9.2x108 1.3x109 1.1x109b 
MRS + 1.2 x109 8.6x108 8.9x108 1.6x109 1.1x109b 
MRS-LA - 2.3 x109 1.0x109 2.1x109 1.5x109 1.7x109a 
MRS-LA + 2.5 x109 1.2x109 9.9x108 1.7x109 1.6x109a 
aMeans in the same column with different superscripts differ (P<0.05)
bMRS, washed cells grown in Man Rogosa and Sharpe broth without 0.2% linoleic acid; MRS-LA,
washed cells grown in Man Rogosa and Sharpe broth with 0.2% linoleic acid
           cGA, 0.3% glycocholic acid; (-) no exposure to, (+) exposure to
           dColony formit units per milliliter
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